Analysis of the structural effects of four novel and a previously known mutations causing factor XI deficiency

• References

• 1 Seligsohn U. Factor XI in haemostasis and thrombosis: past, present and future. Thromb Haemost 2007; 98: 84-89.
• 2 McMullen BA, Fujikawa K, Davie EW. Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains. Biochemistry 1991; 30: 2056-2060.
• 3 Meijers JC, Mulvihill ER, Davie EW. et al. Apple four in human blood coagulation factor XI mediates dimer formation. Biochemistry 1992; 31: 4680-4684.
• 4 Wu W, Sinha D, Shikov S. et al. Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa. J Biol Chem 2008; 283: 18655-18664.
• 5 Gailani D, Broze Jr GJ. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-912.
• 6 Salomon O, Steinberg DM, Tamarin I. et al. Plasma replacement therapy during labor is not mandatory for women with severe factor XI deficiency. Blood Coagul Fibrinol 2005; 16: 37-41.
• 7 Salomon O, Steinberg DM, Seligsohn U. Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy. Haemophilia 2006; 12: 490-493.
• 8 Kravtsov DV, Wu W, Meijers JC. et al. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood 2004; 104: 128-134.
• 9 Kravtsov DV, Monahan PE, Gailani D. A classification system for cross-reactive material-negative factor XI deficiency. Blood 2005; 105: 4671-4673.
• 10 Shpilberg O, Peretz H, Zivelin A. et al. One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 1995; 85: 429-432.
• 11 Zadra G, Asselta R, Malcovati M. et al. Molecular genetic analysis of severe coagulation factor XI deficiency in six Italian patients. Haematologica 2004; 89: 1332-1340.
• 12 Papagrigoriou E, McEwan PA, Walsh PN. et al. Crystal structure of the factor XI zymogen reveals a pathway for transactivation. Nat Struct Mol Biol 2006; 13: 557-558.
• 13 Arnold K, Bordoli L, Kopp J. et al. The SWISSMODEL Workspace: A web-based environment for protein structure homology modelling. Bioinformatics 2006; 22: 195-201.
• 14 Zivelin A, Bauduer F, Ducout L. et al. Factor XI deficiency in French Basques is caused predominantly by an ancestral Cys38Arg mutation in the factor XI gene. Blood 2002; 99: 2448-2454.
• 15 Peretz H, Mulai A, Usher S. et al. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: one of ancient Middle Eastern origin and another of more recent European origin. Blood 1997; 90: 2654-2659.
• 16 Baglia FA, Shrimpton CN, Emsley J. et al. Factor XI interacts with the leucine-rich repeats of glycoprotein Ibalpha on the activated platelet. J Biol Chem 2004; 279: 49323-49329.